Literature DB >> 10644625

Postcontractile force depression in humans is associated with an impairment in SR Ca(2+) pump function.

R Tupling1, H Green, S Grant, M Burnett, D Ranney.   

Abstract

To investigate the hypothesis that intrinsic changes in sarcoplasmic reticulum (SR) Ca(2+)-sequestration function can be implicated in postcontractile depression (PCD) of force in humans, muscle tissue was obtained from the vastus lateralis and determinations of maximal Ca(2+) uptake and maximal Ca(2+)-ATPase activity were made on homogenates obtained before and after the induction of PCD. Eight untrained females, age 20.6+/-0.75 yr (mean +/- SE), performed a protocol consisting of 30 min of isometric exercise at 60% maximal voluntary contraction and at 50% duty cycle (5-s contraction and 5-s relaxation) to induce PCD. Muscle mechanical performance determined by evoked activation was measured before (0 min), during (15 and 30 min), and after (60 min) exercise. The fatiguing protocol resulted in a progressive reduction (P<0.05) in evoked force, which by 30 min amounted to 52% for low frequency (10 Hz) and 20% for high frequency (100 Hz). No force restoration occurred at either 10 or 100 Hz during a 60-min recovery period. Maximal SR Ca(2+)-ATPase activity (nmol x mg protein(-1) x min(-1)) and maximal SR Ca(2+) uptake (nmol. mg protein(-1) x min(-1)) were depressed (P<0.05) by 15 min of exercise [192+/-45 vs. 114+/-8.7 and 310+/-59 vs. 205+/-47, respectively; mean +/- SE] and remained depressed at 30 min of exercise. No recovery in either measure was observed during the 60-min recovery period. The coupling ratio between Ca(2+)-ATPase and Ca(2+) uptake was preserved throughout exercise and during recovery. These results illustrate that during PCD, Ca(2+) uptake is depressed and that the reduction in Ca(2+) uptake is due to intrinsic alterations in the Ca(2+) pump. The role of altered Ca(2+) sequestration in Ca(2) release, cytosolic-free calcium, and PCD remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644625     DOI: 10.1152/ajpregu.2000.278.1.R87

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  6 in total

1.  Frog skeletal muscle fibers recovering from fatigue have reduced charge movement.

Authors:  J D Bruton; P Szentesi; J Lännergren; H Westerblad; L Kovács; L Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

2.  Alterations in peripheral muscle contractile characteristics following high and low intensity bouts of exercise.

Authors:  Martyn G Morris; Helen Dawes; Ken Howells; Oona M Scott; Mary Cramp; Hooshang Izadi
Journal:  Eur J Appl Physiol       Date:  2011-05-10       Impact factor: 3.078

3.  Oxygen delivery and the restoration of the muscle energetic balance following exercise: implications for delayed muscle recovery in patients with COPD.

Authors:  Gwenael Layec; Corey R Hart; Joel D Trinity; Oh-Sung Kwon; Matthew J Rossman; Ryan M Broxterman; Yann Le Fur; Eun-Kee Jeong; Russell S Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

Review 4.  Muscle fatigue: from observations in humans to underlying mechanisms studied in intact single muscle fibres.

Authors:  Nicolas Place; Takashi Yamada; Joseph D Bruton; Håkan Westerblad
Journal:  Eur J Appl Physiol       Date:  2010-04-24       Impact factor: 3.078

5.  Ca²⁺-pumping impairment during repetitive fatiguing contractions in single myofibers: role of cross-bridge cycling.

Authors:  Leonardo Nogueira; Amy A Shiah; Paulo G Gandra; Michael C Hogan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-15       Impact factor: 3.619

6.  Effects of Acute Exercise and Training on the Sarcoplasmic Reticulum Ca2+ Release and Uptake Rates in Highly Trained Endurance Athletes.

Authors:  Kasper Degn Gejl; Erik P Andersson; Joachim Nielsen; Hans-Christer Holmberg; Niels Ørtenblad
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.